OMX Nordic 40
|
2 339,85
|
17,21
|
0,74 %
|
Analysen zu OMX Nordic 40-Werten
| 24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Ericsson Underweight | Barclays Capital | |
| 24.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 24.01.25 | Ericsson Sell | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 24.01.25 | Ericsson Sell | UBS AG | |
| 23.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 23.01.25 | Volvo AB Neutral | UBS AG | |
| 22.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 21.01.25 | Novo Nordisk Buy | UBS AG | |
| 20.01.25 | ABB Underperform | Bernstein Research | |
| 20.01.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 17.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.25 | Novo Nordisk Buy | UBS AG | |
| 17.01.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 16.01.25 | Volvo AB Neutral | UBS AG | |
| 16.01.25 | Novo Nordisk Buy | UBS AG | |
| 16.01.25 | Ericsson Sell | Goldman Sachs Group Inc. | |
| 16.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 15.01.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 15.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 14.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 13.01.25 | Novo Nordisk Buy | UBS AG | |
| 13.01.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 13.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 13.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.01.25 | Ericsson Underperform | Bernstein Research | |
| 12.01.25 | Nokia Market-Perform | Bernstein Research | |
| 10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.01.25 | Volvo AB Sector Perform | RBC Capital Markets | |
| 10.01.25 | ABB Sector Perform | RBC Capital Markets | |
| 08.01.25 | Novo Nordisk Buy | UBS AG | |
| 07.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 07.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | AstraZeneca Outperform | Bernstein Research |
HOT STOCKS DER LETZTEN 3 TAGE
| ABB | 7 |
| Nokia | 3 |
| Hennes & Mauritz AB | 1 |
| Novo Nordisk | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.